Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson's disease onset

MLA

Georgia Xiromerisiou, et al. “Gain-of-Function Variant in GLUD2 Glutamate Dehydrogenase Modifies Parkinson’s Disease Onset.” European Journal of Human Genetics, vol. 18, Oct. 2009, pp. 336–41. EBSCOhost, https://doi.org/10.1038/ejhg.2009.179.

APA

Georgia Xiromerisiou, Beate Ritz, Helen Latsoudis, Cleanthe Spanaki, Konstantinos Kanavouras, Andreas Plaitakis, Spyridon Papapetropoulos, Vasileios Mastorodemos, Nikolas Borompokas, Irene Skoula, Ioannis Zaganas, George Hadjigeorgiou, & Jeff M. Bronstein. (2009). Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson’s disease onset. European Journal of Human Genetics, 18, 336–341. https://doi.org/10.1038/ejhg.2009.179

Chicago

Georgia Xiromerisiou, Beate Ritz, Helen Latsoudis, Cleanthe Spanaki, Konstantinos Kanavouras, Andreas Plaitakis, Spyridon Papapetropoulos, et al. 2009. “Gain-of-Function Variant in GLUD2 Glutamate Dehydrogenase Modifies Parkinson’s Disease Onset.” European Journal of Human Genetics 18 (October): 336–41. doi:10.1038/ejhg.2009.179.